project id: TCGA-CESC; case submitter id: TCGA-EX-A449; source center: 23; state: released; a260 a280 ratio: 1.81; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 1.76; rna integrity number: 8.4; age at index: 42; days to birth: -15559; ethnicity: not hispanic or latino; gender: female; race: white; vital status: Alive; year of birth: 1970; age at diagnosis: 15559; ajcc pathologic m: M1; ajcc pathologic n: NX; ajcc pathologic t: T1b1; classification of tumor: not reported; days to diagnosis: 0; days to last follow up: 447.0; figo stage: Stage IVB; icd 10 code: C53.9; last known disease status: not reported; morphology: 8384/3; primary diagnosis: Adenocarcinoma, endocervical type; prior malignancy: yes; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Cervix uteri; synchronous malignancy: Not Reported; tissue or organ of origin: Cervix uteri; tumor grade: Not Reported; year of diagnosis: 2012; treatment or therapy: yes; alcohol history: Not Reported; is ffpe: false; composition: Not Reported; days to collection: 79; days to sample procurement: 0; initial weight: 360.0; portion submitter id: TCGA-EX-A449-01A-11; percent lymphocyte infiltration: 2.0; percent monocyte infiltration: 1.0; percent necrosis: 10.0; percent neutrophil infiltration: 0.0; percent normal cells: 0.0; percent stromal cells: 0.0; percent tumor cells: 90.0; percent tumor nuclei: 80.0;